July 9, 2026
Lilly to present Alzheimer's disease diagnostic and therapeutic research at AAIC 2026, including new data on P-tau217 blood tests and amyloid-targeting treatment
Investors
Clinical Development Pipeline
Learn More
Quarterly Results
View Results
2025 Year in Review
View This Report
Key Ratios
Key Financial Ratios
Sustainability Report
Learn More
Latest Sustainability Developments
View Stories
Investor Email Alerts
Sign up to receive email alerts for various types of investor content.